Description

Gliucofaj XR Tablets with Prolonged Release 1000 mg. №60

Ingredients:

Each tablet contains 1000 mg of Metformin Hydrochloride.

Dosage:

The usual dose is one tablet once a day with the evening meal.

Indications:

Gliucofaj XR tablets are indicated for the treatment of type 2 diabetes mellitus.

Contraindications:

Do not use in patients with renal impairment, acute or chronic metabolic acidosis, or hypersensitivity to metformin.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Studies have shown that Gliucofaj XR tablets with prolonged release 1000 mg are effective in lowering blood glucose levels in patients with type 2 diabetes. The extended-release formulation provides a steady release of metformin, leading to better glycemic control throughout the day.

Additional Information:

Gliucofaj XR is a well-tolerated medication with a low risk of hypoglycemia. It is commonly prescribed as a first-line treatment for type 2 diabetes due to its proven efficacy and safety profile.

Research has also indicated that metformin, the active ingredient in Gliucofaj XR, may have additional benefits beyond glycemic control, such as reducing the risk of cardiovascular events in diabetic patients.